- All address
- BFA,Main Hall,Level 2
- BFA,Main Hall1/2-A,Level 2
- BFA,Main Hall1/2-B,Level 2
- BFA,Dong Yu Grand Ballroom A
- BFA,Dong Yu Grand Ballroom B
- BFA,Dong Yu Grand Ballroom C
- BFA,Dong Yu Grand Ballroom D
- BFA,Peacock Room 1
- Dongyu,Changyan room(Wanquan Ballroom 1/3)
- Dongyu,Yiyong room(Wanquan Ballroom 1/3)
- Dongyu,Hesheng room(Wanquan Ballroom 1/3)
- BFA,The Pavilion
- BFA,Princess Palm
- ALL
- Food Regulations and Standards——Latest Progress in Regulations and Standards
- Food Regulations and Standards——Current Status and Challenges of Food Claims
- Food Regulations and Standards——Nutrition Policy
- New Technologies and New Products——Foods from Synthetic Biology
- New Technologies and New Products——Efficacy and Evidence-Based Applications of Ergothioneine
- New Technologies and New Products——New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications
- New Technologies and New Products——Functional Lipids and Nutritional Health Research
- New Technologies and New Products——Innovation of Iterative Algal Oil and Evidence for Its Human Health Functions
- Medicine and Food Homology (MFH)——Comprehensive Topics
- Medicine and Food Homology (MFH) ——Goji Berry
- Sports Foods——Comprehensive Theme
- Sports Foods——Sports Drink
- Sports Foods——Sports Nutritional Food
- Sports Foods——Roundtable Meeting
- Foods for Special Medical Purposes (FSMPs)——Accelerating Market Access to Improve the Availability of Special Medical Foods
- Foods for Special Medical Purposes (FSMPs)——Industry Empowerment:New Perspectives on Medical Food
- Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting
- Probiotics,Prebiotics and Postbiotics——Precision Nutrition and Personalized Probiotic Solutions
- Probiotics,Prebiotics and Postbiotics——Probiotics and Health Across the Whole Life Cycle
- Probiotics,Prebiotics and Postbiotics——Synthetic Biology and Next-Generation Probiotic Development
- Probiotics,Prebiotics and Postbiotics——From Gut to Brain,Skin,and Metabolism
- Probiotics,Prebiotics and Postbiotics——Postbiotics
- Probiotics,Prebiotics and Postbiotics——Prebiotics
- Healthy Grains——Whole Grain Foods and Health
- Section VII:Healthy Grains——Section2:Low-GI Staple Foods and Health
- Infant and Toddler Formula Milk Powder and Complementary Food——Tracking Scientific Research Achievements and Ingredient Innovation
- Infant and Toddler Formula Milk Powder and Complementary Food——Precise Formulation and Clinical Evidence
- Infant and Toddler Formula Milk Powder and Complementary Food——Infant Complementary Food
Sessions
Section I:Food Regulations and Standards——Session 1:Latest Progress in Regulations and Standards |
2026-03-12 14:00-17:10 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator:Huo Junsheng,Research Fellow,National Institute for Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-12 14:00-14:20 New Developments in the Administration of Special FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:20-14:40 Challenges and Reflections on the Administration of Infant Formula and Medical FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:40-15:00 New Progress in the Administration of Health FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 15:20-15:40 Practice in the Evaluation of New Functions of Health Foods |
| 2026-03-12 15:40-16:00 Development of the List of Health Food Raw MaterialsDirector Sa Yi,Food Evaluation Center of the State Administration for Market Regulation |
| 2026-03-12 16:00-16:15 Reflections on the R&D of Milk Components and the Formulation of Their Standards |
| 2026-03-12 16:15-16:30 Latest Updates on Food Standards for Special Medical Purposes (FSMP) |
| 2026-03-12 16:30-16:45 Policy Practice of Temporary Import of Food for Special Medical Purposes (FSMP) and Health Food in Hainan Boao Lecheng Pilot ZoneAdministration of Boao Lecheng International Medical Tourism Pilot Zone,Hainan |
| 2026-03-12 16:45-17:10 Q&A |
Section I:Food Regulations and Standards——Session 2:Current Status and Challenges of Food Claims |
2026-03-13 09:00-12:00 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator:Fan Yongxiang,Deputy Director,China National Center for Food Safety Risk Assessment (CFSA);Che Huilian,Professor,China Agricultural University (CAU) |
| 2026-03-13 09:00-09:20 Forward-looking Thinking on Food Claim Management |
| 2026-03-13 09:20-09:40 Overview of Global Regulatory Systems for Food Claims |
| 2026-03-13 09:40-10:00 Demand and Challenges of Food ClaimsTBC |
| 2026-03-13 10:00-10:20 Introduction to the“General Standard for Food Claims” |
| 2026-03-13 10:20-10:40 Research Progress on health claim of food and medicine continuum |
Recess |
| 2026-03-13 10:50-11:55 Roundtable Meeting：The Development Path of Food Claims in China |
| 2026-03-13 11:55-12:00 |
Section I:Food Regulations and Standards——Session 3:Nutrition Policy |
2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom A |
| |
| 2026-03-14 09:00-09:30 |
| 2026-03-14 09:30-10:00 |
| 2026-03-14 10:00-10:30 |
| 2026-03-14 10:30-11:00 |
| 2026-03-14 11:00-11:30 |
| 2026-03-14 11:30-12:00 |
Section II:New Technologies and New Products——Session 1:Foods from Synthetic Biology |
2026-03-12 13:30-17:30 BFA,Princess Palm |
Moderator： |
| 2026-03-12 13:30-13:55 Management Status,Future Prospects and Key Challenges of Synthetic Biology-Derived Novel Food Ingredients |
| 2026-03-12 13:55-14:20 Biofabrication of Vitamins:Key Essential Nutrients via Biotechnological Routes |
| 2026-03-12 14:20-14:45 Biomanufacturing of Functional Food Components Driven by Artificial Intelligence |
| 2026-03-12 14:45-15:10 Developing cell factories for edible mycoprotein biomanufacturing |
| 2026-03-12 15:10-15:35 FoodSeek Large Model |
| 2026-03-12 15:35-16:00 Pilot Production and Comprehensive Safety Assessment of In Vitro Cultured Porcine Meat |
| 2026-03-12 16:00-16:25 Precision-Fermented Lactoferrin:Functional Validation,Commercialisation and Advances Towards Human-Identical Lactoferrin |
| 2026-03-12 16:25-17:20 Roundtable Meeting：Development and Challenges of Synbio Foods |
| 2026-03-12 17:20-17:30 |
Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine |
2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderator：He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation |
| 2026-03-14 09:00-09:20 Synthetic Biology of Ergothioneine and Investigation into Its Anti-Aging Properties |
| 2026-03-14 09:20-09:40 Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence |
| 2026-03-14 09:40-10:00 Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies |
| 2026-03-14 10:00-10:20 |
| 2026-03-14 10:20-10:40 The protective effect of ergothioneine on oxidative damage of nerve cells |
| 2026-03-14 10:40-11:00 Green Biomanufacturing,Efficacy and Applications of Ergothioneine |
| 2026-03-14 11:00-11:55 Roundtable Meeting：The Development Path of Ergothioneine in China |
| 2026-03-14 11:55-12:00 |
Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications |
2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderators: |
| 2026-03-14 08:30-08:50 Chinese HMOs Profile:Research and Application |
| 2026-03-14 08:50-09:10 Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults |
| 2026-03-14 09:10-09:30 The trends of regulatory management of HMOs |
| 2026-03-14 09:30-09:50 The Potential Application Value of HMOs in the Field of Healthy Aging |
| 2026-03-14 09:50-10:10 Protective and Mitigative Effects of HMO Combined with Probiotics on Necrotizing EnterocolitisCapitolab |
| 2026-03-14 10:10-10:30 The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways |
| 2026-03-14 10:30-10:50 Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio |
| 2026-03-14 10:50-11:10 Global Trends in HMO Research and Applications |
| 2026-03-14 11:10-11:40 Roundtable Meeting：Risks of Biosynthetic Human Milk Oligosaccharides (HMOs) Applied in the Production of Infant and Toddler Formula Milk Powder |
Section II:New Technologies and New Products——Session 4:Functional Lipids and Nutritional Health Research |
2026-03-13 08:30-17:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderator:Wang Xingguo,Professor,Jiangnan University |
| 2026-03-13 08:30-08:50 Guiding report:Health prospects for functional oils |
| 2026-03-13 08:50-09:20 Ocean-derived Omega-3 fatty acids and health:From molecular mechanisms to new nutrition strategies throughout the life cycle |
| 2026-03-13 09:20-09:50 Prospective dietary fat assessment using human metabolic chambers,nutritional challenges,and interventions |
| 2026-03-13 09:50-10:20 n-3 fatty acids improve cognitive function by regulating epigenetic genes |
Recess |
| 2026-03-13 10:35-11:00 Nutritional mechanisms and strategies of food lipids regulating brain health |
| 2026-03-13 11:00-11:25 Fat-gut microbiome interaction and metabolic health |
| 2026-03-13 11:25-11:50 Fat nutrition and metabolism in maternal and child health--Molecular epidemiological study |
| 2026-03-13 11:50-12:15 Effects of different ratios of n6/n3 oils on health |
| |
| 2026-03-13 13:30-13:55 The requirements for fat and fatty acids in special dietary foods |
| 2026-03-13 13:55-14:20 Nutritional Functions and Applications of high sn-2 DHA Functional Lipids |
| 2026-03-13 14:20-14:45 ASSESSMENT OF DIETARY TOTAL FAT,SATURATED FATTY ACID AND UNSATURATED FATTY ACID INTAKE IN CHINESE RESIDENTS |
| 2026-03-13 14:45-15:10 AI+ intelligent manufacturing empowers the development of functional oils |
| 2026-03-13 15:10-15:35 Eat more healthy:Yihai-Kerry's research development in functional oils |
| 2026-03-13 15:35-16:00 Functional fats for life cycle nutrition |
| 2026-03-13 16:00-16:25 Structured Lipids for Improving Malnutrition in Patients with Chronic Obstructive Pulmonary Disease:A Randomized Clinical Study |
Recess |
| 2026-03-13 16:40-17:40 Roundtable Meeting |
Section II:New Technologies and New Products——Session 5:Innovation of Iterative Algal Oil and Evidence for Its Human Health Functions |
2026-03-12 13:00-16:00 BFA,The Pavilion |
Moderators:Prof. Shan Zhilei,School of Public Health,Tongji Medical College,Huazhong University of Science and Technology;Pan Yu,Director of Scientific Affairs,DSM-Firmenich Greater China |
| 2026-03-12 13:00-13:25 Leading the global innovation and new breakthroughs in clinical evidence of algal Omega-3 |
| 2026-03-12 13:25-13:55 In-depth interpretation of DO Health,the world's largest anti-aging clinical research |
| 2026-03-12 13:55-14:20 The crucial role of Omega-3 in metabolic health |
| 2026-03-12 14:20-14:45 The scientific potential of the anti-inflammatory mechanism of Omega-3 in health management |
| 2026-03-12 14:45-15:05 The latest clinical research on the reduction of preterm birth by Omega-3 for guiding pregnant nutrition |
| 2026-03-12 15:05-15:30 Health Benefits of Life's Nutritional Lipids for Children and Teenagers |
| 2026-03-12 15:30-16:00 Roundtable Meeting |
Section III:Medicine and Food Homology (MFH)——Session 1:Comprehensive Topics |
2026-03-12 13:00-17:10 BFA,Dong Yu Grand Ballroom A |
Moderator:Chen Min,Research Fellow,Chairman of the Professional Committee for Evaluation and Utilization of Medicine and Food Homology Substances,China Association of Chinese Materia Medica |
| 2026-03-12 13:00-13:10 |
| 2026-03-12 13:10-13:40 Current Development Status and Future Trends of the Global Functional Food Industry |
| 2026-03-12 13:40-14:00 National Priority Work on Food and Medicinal Materials |
| 2026-03-12 14:00-14:20 Health Preservation Philosophy Based on the Spleen-Stomach Theory and Its Contemporary Practice |
| 2026-03-12 14:20-14:40 Interpretation of the Evaluation System and Standards for Nutraceutical Medicinal Diets |
| 2026-03-12 14:40-15:00 From Traditional Insights to Modern Clinical Medicine:The Application of Homology of Medicine and Food in Preventive Healthcare |
| 2026-03-12 15:00-15:20 Application of the Medicine-Food Homology Concept in Nestlé's R&D and Innovation |
| 2026-03-12 15:20-15:40 Admission Standards for Medicinal and Edible Homologous Products in the "Medicine-Food Homology Database"Assoc. Res. Yang Guang,CACMS National Resource Center for Chinese Materia Medica |
| 2026-03-12 15:40-16:00 From Cellular Level to Organ Level:Plant-Derived Scientific Anti-Aging SolutionsWang Feijie,Amway (China) Daily Necessities Co.,Ltd. |
| 2026-03-12 16:00-16:10 Launch Ceremony of China’s Medicinal &Edible Homology Industry Development Report 2025Assoc. Res. Yang Guang,CACMS National Resource Center for Chinese Materia Medica |
| 2026-03-12 16:10-17:10 Roundtable Meeting：Standards for Food and Medicine Homology Substances and Products |
Section III:Medicine and Food Homology (MFH) ——Session 2:Goji Berry |
2026-03-12 16:10-18:40 BFA,The Pavilion |
Keep Pace with Global Health Food Tech,Fuel Industrial Innovation:Wolfberry’s High-Value Development Model |
| 2026-03-12 16:10-16:15 Opening SpeechTBC |
| 2026-03-12 16:15-16:30 Guiding Report:Goji Berry and Human Health |
| 2026-03-12 16:30-16:40 Speech by LeaderTBC |
| 2026-03-12 16:40-17:00 Research on the Material Basis of Medicine-Food Homology Contributes to Developing Potential New Drugs for Parkinson's Disease |
| 2026-03-12 17:00-17:20 The Application of Lycium Barbarum Polypeptide in Eye Diseases |
| 2026-03-12 17:20-17:35 Research Progress on the Main Active Components of Lycium barbarum |
| 2026-03-12 17:35-17:50 From Traditional Herb to Functional Food:The Evolution and Brand Story of Black Wolfberry |
| 2026-03-12 17:50-18:05 Efficient Exploration and Commercial Application of High-Value Added Active Compounds from Goji Berry |
| 2026-03-12 18:05-18:35 Roundtable Meeting：Market Changes and New Transformation Paths of Wolfberry ProductsTBC |
| 2026-03-12 18:35-18:40 Conference Summary and Closing |
Section IV:Sports Foods——Session 1:Comprehensive Theme |
2026-03-13 09:00-10:20 BFA,Dong Yu Grand Ballroom C |
Moderator:Professor Qiu Junqiang,Head of the Exercise Biochemistry Division,School of Human Movement Sciences,Beijing Sport University |
The Scientific Rationale Underpinning Sports Nutrition Products |
| 2026-03-13 09:00-09:20 Guiding Report:Sports Nutrition in the Context of Healthy China |
| 2026-03-13 09:20-09:40 A Senolytic Sports Supplement for Muscle Renewal：Senactiv® |
| 2026-03-13 09:40-10:00 The Chronobiology of Nutrition:Impact of Time-Restricted Eating Combined with Exercise on Health and Exercise Performance |
| 2026-03-13 10:00-10:20 Procedures and Methods for Evaluating the Efficacy of Sports Nutraceuticals |
Section IV:Sports Foods——Session 2：Sports Drink |
2026-03-13 10:40-12:00 BFA,Dong Yu Grand Ballroom C |
Moderator:Professor Qiu Junqiang,Head of the Exercise Biochemistry Division,School of Human Movement Sciences,Beijing Sport University |
| 2026-03-13 10:40-11:00 |
| 2026-03-13 11:00-11:20 Nutritional considerations in a warming world |
| 2026-03-13 11:20-11:40 Sweat Physiological Characteristics in the Chinese Population |
| 2026-03-13 11:40-12:00 Effects of Branched-Chain Amino Acid Supplementation on Delayed Onset Muscle Soreness After Running |
Section IV:Sports Foods——Session 3：Sports Nutritional Food |
2026-03-13 14:00-15:20 BFA,Dong Yu Grand Ballroom C |
Moderator:Professor Qiu Junqiang,Head of the Exercise Biochemistry Division,School of Human Movement Sciences,Beijing Sport University |
| 2026-03-13 14:00-14:20 MFGM for Supporting Immune Health in Sports and Active Lifestyles |
| 2026-03-13 14:20-14:40 From Evidence to the Future:A Full-Chain Exploration of How Sports Nutrition Empowers Efficient Muscle Gain |
| 2026-03-13 15:00-15:20 Unleashing the Potential of Slow Proteins:Sustained Absorption and Formulation Empowerment of Caseinate in Sports and Nutritional Foods |
Section IV:Sports Foods——Roundtable Meeting |
2026-03-13 15:30-16:30 BFA,Dong Yu Grand Ballroom C |
| 2026-03-13 15:30-16:30 Roundtable Meeting:Technological Innovation and Challenges of Sports Nutrition FoodsModerator: |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 1:Accelerating Market Access to Improve the Availability of Special Medical Foods |
2026-03-13 13:00-14:30 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 13:00-13:15 Guiding Report:A Decade of Development Review and Future Outlook for Food for Special Medical Purposes (FSMP) |
| 2026-03-13 13:15-13:30 Sharing of the Huai'an ModelTBC |
| 2026-03-13 13:30-13:45 Market Access Status and Channels of Medical Food Products in Europe |
| 2026-03-13 13:45-14:00 Clinical Application of Medical Food for Special Purposes in Asia-Pacific Nations:Illustrations from Singapore and AustraliaAnna Jacob，Abbot Consultant |
| 2026-03-13 14:00-14:15 Demand,Market Access and Clinical Application of Food for Special Medical Purposes (FSMP) for Rare DiseasesYang Yanling Chief Physician,Peking University First Hospital (PUFH) |
| 2026-03-13 14:15-14:30 Medical Food in Taiwan:Marketing Strategies Under Stringent Regulatory FrameworkChia Tai Goody |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 2:Industry Empowerment:New Perspectives on Medical Food |
2026-03-13 14:40-16:25 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 14:40-14:55 Application of Complete Formula Whole-Food-Based Food for Special Medical Purposes (FSMP) in Overseas MarketsSanchez Natahel，Nestlé Health Science Global Marketing Department |
| 2026-03-13 14:55-15:10 Clinical Practice and Existing Challenges of Partially Hydrolyzed Protein-Based Formulas |
| 2026-03-13 15:10-15:25 |
| 2026-03-13 15:25-15:40 Design Strategies for Special Nutritional Products Targeting Blood Glucose Management in Patients with Renal Dialysis Requirements |
| 2026-03-13 15:40-15:55 The Role of Custom-Tailored and Optimized Whey Protein Formulas in Nutritional Management of Chronic Kidney Disease (CKD) |
| 2026-03-13 15:55-16:10 The Indispensable and Versatile Applications of Caseinates in Clinical Nutrition Support |
| 2026-03-13 16:10-16:25 |
Section V:Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting |
2026-03-13 16:30-17:00 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
| 2026-03-13 16:30-17:00 Roundtable Meeting |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 1:Precision Nutrition and Personalized Probiotic Solutions |
2026-03-12 13:30-16:05 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-12 13:30-13:35 Opening Speech |
| 2026-03-12 13:35-13:55 Global Development Pattern of the Probiotics &Prebiotics Field |
| 2026-03-12 13:55-14:15 State-of-the-Art Progress in Gut Microbiota and Precision Nutrition:From Research to Translation |
| 2026-03-12 14:15-14:35 Precision Assessment of Dietary Fat Intake and Prediction of Metabolic Health via Integration of Metabolic Chambers,Nutritional Challenges,Multi-Omics and Population Cohort Studies |
| 2026-03-12 14:35-14:55 Gut Microecology from the Perspective of Precision Nutrition:Probiotics Supporting Metabolic Balance.Johanna Maukonen,IFF Health SciencesGlobal Director,Clinical Innovatrion and Translation、Technical Fellow |
| 2026-03-12 14:55-15:15 Innovation &Branding Integration:Hi188,the Growth-Promoting Probiotic |
| 2026-03-12 15:15-15:35 Formulation Innovations in Individualized Probiotic Products |
| 2026-03-12 15:35-16:05 Roundtable Meeting |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 2:Probiotics and Health Across the Whole Life Cycle |
2026-03-13 13:00-15:45 BFA,Main Hall1/2-A,Level 2 |
| |
| 2026-03-13 13:00-13:10 |
| 2026-03-13 13:10-13:35 Translating Chinese Human Milk Insights into HMO Applications in Early Life Nutrition |
| 2026-03-13 13:35-14:00 Fresh Raw Materials Empower a New Era of Whole-Lifecycle Nutrition |
| 2026-03-13 14:00-14:25 Impact of Gut Microbiota and Bioactive Factors During Pregnancy on Maternal and Infant Health |
| 2026-03-13 14:25-14:50 Unlocking longevity - exploring the microbiome's role in healthy agingMikkel Jungersen,Novonesis， Human Health Biosolutions Head of Clinical Development,Director |
| 2026-03-13 14:50-15:00 |
| 2026-03-13 15:00-15:45 Roundtable Meeting |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 3:Synthetic Biology and Next-Generation Probiotic Development |
2026-03-13 09:00-12:00 BFA,Main Hall1/2-A,Level 2 |
| |
| 2026-03-13 09:00-09:05 Opening Speech |
| 2026-03-13 09:05-09:25 |
| 2026-03-13 09:25-09:45 TBC |
| 2026-03-13 09:45-10:05 TBC |
| 2026-03-13 10:05-10:25 |
| 2026-03-13 10:25-10:45 |
| 2026-03-13 11:05-11:25 |
| 2026-03-13 11:25-12:00 |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 4:From Gut to Brain,Skin,and Metabolism |
2026-03-12 16:15-18:05 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-12 16:15-16:35 Scientific Breakthroughs Driving Innovation in Probiotic Products |
| 2026-03-12 16:35-16:55 Gut-Brain-Metabolic Axis:Unlocking Probiotic Potential for Holistic Health |
| 2026-03-12 16:55-17:15 Probiotics Research Institute:Gut-Brain Axis and HRB Bifidobacterium for Healthy Aging |
| 2026-03-12 17:15-17:35 Gut Microbiota:Diverse Strategies and Synergistic Mechanisms for Gut-Brain Axis Intervention in Parkinson's Disease |
| 2026-03-12 17:35-18:05 Roundtable Meeting |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 5:Postbiotics |
2026-03-14 09:00-11:00 BFA,Dong Yu Grand Ballroom C |
| 2026-03-14 09:00-09:20 |
| 2026-03-14 09:20-09:40 Post LB Postbiotics and the Intestinal Barrier:Current Scientific Evidence and Novel Insights |
| 2026-03-14 09:40-10:00 Postbiotics for Emotional Well-being:Clinical Evidence from Morinaga’s LAC-living+ Research |
| 2026-03-14 10:00-10:20 New Randomized Controlled Trial Findings of Gastric-Derived Lactobacillus johnsonii LJ88 for Gastric Health |
| 2026-03-14 10:20-11:00 Roundtable Meeting |
Section VI:Probiotics,Prebiotics and Postbiotics——Session 6:Prebiotics |
2026-03-13 09:10-10:40 BFA,Peacock Room 1 |
| |
| 2026-03-13 09:10-09:40 Nutrition improving gut discomfort symptoms and health（TBC） |
| 2026-03-13 09:40-10:10 Harnessing the power of the gut（TBC）Nestle NR Scientist |
| 2026-03-13 10:10-10:40 Gut Microbiota:Prebiotics Empowering Healthy Aging |
Section VII:Healthy Grains——Section1:Whole Grain Foods and Health |
2026-03-13 08:30-12:10 BFA,Dong Yu Grand Ballroom D |
Moderators:Ding Gangqiang,Chief Physician,Chief Expert of the Institute of Nutrition and Health,China Center for Disease Control and Prevention;Tan Bin,Research Fellow,Chief Scientist,Science and Technology Research Institute,State Administration of Grain and Material Reserves |
| 2026-03-13 08:30-08:40 Guiding Report：Future Trends of Nutritious Whole Grains |
| 2026-03-13 08:40-09:00 Grains Supporting Students' Growth and Health:A Study on Their Critical Functions in Nutritious Catering and the Supporting System of Domestic and International Policies,Regulations,and Standards |
| 2026-03-13 09:00-09:20 Health Benefits and Efficacy of Fermented Oats |
| 2026-03-13 09:20-09:40 Nutritional Health and Industrial Innovation Practices of Functional Whole-Grain Rice |
| 2026-03-13 09:40-10:00 Progress and Outlook on the Construction of China's Whole-Grain Standard System |
| 2026-03-13 10:00-10:20 Industrial Development Trend and Application Outlook of Whole-Grain Ingredients (Whole Wheat Flour) |
| 2026-03-13 10:20-10:40 Overview and Application Outlook of Functional Wheat Development |
| 2026-03-13 10:40-11:00 Development Strategies and Directions for Whole-Grain Meals |
| 2026-03-13 11:00-11:20 Whole Grain Highland Barley Products and Their Industrial Practices |
| 2026-03-13 11:20-11:40 Technological Innovation Empowers the Improvement of Accessibility to Whole-Grain Foods in China |
| 2026-03-13 11:40-12:10 Roundtable Meeting |
Section VII:Healthy Grains——Section2:Low-GI Staple Foods and Health |
2026-03-13 14:00-16:20 BFA,Dong Yu Grand Ballroom D |
| 2026-03-13 14:00-14:20 Guiding Report：Clinical and Nutritional Strategies for Blood Glucose Regulation (TBC) |
| 2026-03-13 14:20-14:30 Clinical Study on Low GI Rice in Reducing Postprandial Blood Glucose Fluctuations |
| 2026-03-13 14:30-14:45 Group Standard for Naturally Low Glycemic Index Rice:Scientific Basis and Industrial Implementation |
| 2026-03-13 14:45-15:00 The Scientific Truth About the GI Values of Cereal Foods:Whole Grains ≠ Low GI |
| 2026-03-13 15:00-15:10 Exploration of Innovative Co-construction Models for a Diversified Low Glycemic Index Industry EcosystemTBC |
| 2026-03-13 15:10-15:20 The Development Journey of Low-GI Corn |
| 2026-03-13 15:20-15:30 Innovation in the Low Glycemic Index Healthy Staple Rice Industry Based on Full-Supply-Chain Traceability |
| 2026-03-13 15:30-15:40 Application Research on Wearable Devices in Low Glycemic Index Diet ManagementTBC |
| 2026-03-13 15:40-16:20 Roundtable Meeting：From Scientific Research to Consumer Demand:Exploration of Diversified Category Innovation Mechanisms in the Low Glycemic Index Health Industry |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 1:Tracking Scientific Research Achievements and Ingredient Innovation |
2026-03-13 13:30-15:50 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
| 2026-03-13 13:30-13:35 |
| 2026-03-13 13:35-13:50 Guiding Report： Precision Formulation Design and Biofabrication of Next-Generation Infant Formula |
| 2026-03-13 13:50-14:05 |
| 2026-03-13 14:05-14:20 Establishment,Standardization and Application of a National Human Milk and Maternal-Infant Nutrition Database in China |
| 2026-03-13 14:20-14:35 Deciphering the Structural Diversity and Synergism of Human Milk Oligosaccharides (HMOs):Latest Advances in Infant Nutrition Science and Clinical Research |
| 2026-03-13 14:35-14:50 Synbiotics:Regulation of Infant Gut Microbiota and Immune Development |
| 2026-03-13 14:50-15:05 Studies on the Short- and Long-Term Health Outcomes of Milk Fat Globule Membrane (MFGM) in Infants and Toddlers |
| 2026-03-13 15:05-15:20 Advances in Research and Application of Structured Lipids Mimicking Human Milk Fat |
| 2026-03-13 15:20-15:35 Digital Technology Empowers Precision Health Management for Infants |
| 2026-03-13 15:35-15:50 |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 2:Precise Formulation and Clinical Evidence |
2026-03-13 15:50-17:35 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
| 2026-03-13 15:50-16:05 Based on Human Milk Research:Investigation of 3D Fat Globule-Mediated Effects on Infant Health |
| 2026-03-13 16:05-16:20 Infant Brain and Immune Maturation:Rational Design and Clinical Validation of Human Milk-Mimetic Infant Formulas |
| 2026-03-13 16:20-16:35 |
| 2026-03-13 16:35-16:50 A Randomized,Double-Blind,Placebo-Controlled Study Evaluating the Impact of OPO-Enriched Infant Formula on Fat and Calcium Bioavailability,and Infant Defecatory Characteristics |
| 2026-03-13 16:50-17:05 The Health-Promoting Effects of Lactoferrin During Early Life:A Real-World Study in Chinese Infants |
| 2026-03-13 17:05-17:20 Health-Promoting Effects and Clinical Evaluation of Next-Generation HMO-Enriched Formulas |
| 2026-03-13 17:20-17:35 Impact of Bifidobacterium infantis YLGB-1496 Isolated from Chinese Human Milk on the Health Status of Infants and Toddlers Aged 0–36 Months |
Section VIII:Infant and Toddler Formula Milk Powder and Complementary Food——Section 3:Infant Complementary Food |
2026-03-13 09:00-12:00 BFA,The Pavilion |
| |
| 2026-03-13 09:00-09:25 |
| 2026-03-13 09:25-09:50 |
| 2026-03-13 09:50-10:15 |
| 2026-03-13 10:15-10:40 |
| 2026-03-13 10:40-11:05 |
| 2026-03-13 11:05-11:30 |
| 2026-03-13 11:30-12:00 |